MCA
ABBV icon

Millennium Capital Advisors’s AbbVie ABBV Stock Holding History

Millennium Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Sell
11,769
-90
-0.8% -$19.4K 1.61% 13
2026
Q1 		$2.58M Sell
11,859
-16
-0.1% -$3.55K 1.59% 15
2025
Q4 		$2.71M Sell
11,875
-80
-0.7% -$18.2K 1.6% 13
2025
Q3 		$2.77M Sell
11,955
-504
-4% -$103K 1.67% 13
2025
Q2 		$2.31M Sell
12,459
-91
-0.7% -$16.9K 1.54% 14
2025
Q1 		$2.63M Sell
12,550
-193
-2% -$37.5K 1.94% 9
2024
Q4 		$2.26M Sell
12,743
-10,040
-44% -$1.85M 1.55% 13
2024
Q3 		$4.5M Sell
22,783
-502
-2% -$93.7K 2.94% 7
2024
Q2 		$3.99M Buy
23,285
+3
+0% +$497 2.66% 7
2024
Q1 		$4.24M Buy
23,282
+3
+0% +$517 3% 7
2023
Q4 		$3.61M Sell
23,279
-297
-1% -$43.3K 2.76% 8
2023
Q3 		$3.51M Sell
23,576
-902
-4% -$132K 3% 5
2023
Q2 		$3.3M Sell
24,478
-5,993
-20% -$879K 2.71% 7
2023
Q1 		$4.86M Sell
30,471
-87
-0.3% -$13.3K 4.35% 3
2022
Q4 		$4.94M Sell
30,558
-216
-0.7% -$33.1K 4.99% 2
2022
Q3 		$4.13M Buy
30,774
+146
+0.5% +$21K 4.36% 3
2022
Q2 		$4.69M Buy
30,628
+6
+0% +$917 4.58% 2
2022
Q1 		$4.96M Sell
30,622
-185
-0.6% -$26.9K 4% 3
2021
Q4 		$4.17M Buy
+30,807
New +$3.64M 3.25% 6

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Millennium Capital Advisors's ABBV Position: Q2 2026 in Review

Millennium Capital Advisors reduced its AbbVie (ABBV) stake by 0.76% in Q2 2026, selling an estimated $19.4K and leaving 11,769 shares worth $2.96M. The position accounts for 1.61% of the portfolio, ranked #13.

Millennium Capital Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.96M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Millennium Capital Advisors held 11,769 shares of AbbVie worth $2.96M as of Q2 2026.
  • Millennium Capital Advisors sold 90 AbbVie shares in Q2 2026, an estimated $19.4K.
  • AbbVie made up 1.61% of Millennium Capital Advisors's portfolio in Q2 2026, its #13 holding.
  • Millennium Capital Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Millennium Capital Advisors's AbbVie position peaked at $4.96M in Q1 2022.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Millennium Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.